<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <title>DSpace Collection:</title>
  <link rel="alternate" href="http://repository.usmf.md:80/handle/20.500.12710/278" />
  <subtitle />
  <id>http://repository.usmf.md:80/handle/20.500.12710/278</id>
  <updated>2026-04-19T22:57:38Z</updated>
  <dc:date>2026-04-19T22:57:38Z</dc:date>
  <entry>
    <title>Eficacitatea tratamentului cu acetilcisteină şi extract uscat de frunză de iederă (hederae helix) în bronşita cronică obstructivă</title>
    <link rel="alternate" href="http://repository.usmf.md:80/handle/20.500.12710/5998" />
    <author>
      <name>Tcaciuc, Angela</name>
    </author>
    <id>http://repository.usmf.md:80/handle/20.500.12710/5998</id>
    <updated>2019-06-26T11:47:23Z</updated>
    <published>2013-01-01T00:00:00Z</published>
    <summary type="text">Title: Eficacitatea tratamentului cu acetilcisteină şi extract uscat de frunză de iederă (hederae helix) în bronşita cronică obstructivă
Authors: Tcaciuc, Angela
Abstract: In this clinical study were involved 60 patients with chronic obstructive bronchitis in&#xD;
exacerbations, that were divided in two groups. The first group (n=30) received standard&#xD;
treatment in association with acetylcysteine 200 mg three times per day and dry extract of ivy&#xD;
leaf (50,4 mg). The second group (n=30) used only standard treatment during a period of 10&#xD;
days. The association of acetylcysteine with dry extract of ivy leaf in the treatment of the chronic&#xD;
obstructive bronchitis in exacerbation significantly contributed to the decreasing of the adhesion&#xD;
and viscosity of sputum, as well it contributed to the expectoration efficiency. It is important to&#xD;
mention that the treatment with this mucolytic and expectorant didn't influence other clinical and&#xD;
paraclinical parameters like cough and dyspnoea.&#xD;
&#xD;
&#xD;
&#xD;
&#xD;
&#xD;
Studiul dat a inclus 60 de pacienţi cu bronşită cronică obstructivă în fază de exacerbare.&#xD;
Pacienţii au fost divizaţi în 2 loturi: lotul nr. 1 (n=30), unde la tratamentul standard s-a asociat&#xD;
acetilcisteină câte 200 mg de 3 ori/zi plus 50,4 mg de extract uscat din frunză de iederă (Hederae&#xD;
folium) şi lotul nr. 2 (n=30), unde a fost administrat numai tratament standard timp de 10 zile.&#xD;
Asocierea acetilcisteinei şi extractului uscat din frunză de iederă în tratamentul bolnavilor cu&#xD;
bronsită cronică obstructivă în acutizare a micșorat adeziunea şi vâscozitatea sputei, contribuind&#xD;
la eficientizarea expectorației. Este important de menţionat că terapia cu mucolitice şi&#xD;
expectorante nu a influențat alți parametri clinici și paraclinici examinați, precum sunt tusea şi&#xD;
dispneea
Description: Clinica Medicală nr. 3, Departamentul Medicină Internă, USMF „Nicolae Testimiţanu”</summary>
    <dc:date>2013-01-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Depistarea tuberculozei pulmonare în grupele de risc ftizic sporit printre populaţia urbană</title>
    <link rel="alternate" href="http://repository.usmf.md:80/handle/20.500.12710/5995" />
    <author>
      <name>Iavorschi, Constantin</name>
    </author>
    <author>
      <name>Emelianov, Oleg</name>
    </author>
    <author>
      <name>Brumaru, Albina</name>
    </author>
    <author>
      <name>Bolotnicov, Valentina</name>
    </author>
    <author>
      <name>Ciubotaru, Viorica</name>
    </author>
    <author>
      <name>Bilevici, Tatiana</name>
    </author>
    <author>
      <name>Chipric, Nelli</name>
    </author>
    <id>http://repository.usmf.md:80/handle/20.500.12710/5995</id>
    <updated>2019-06-26T11:47:23Z</updated>
    <published>2013-01-01T00:00:00Z</published>
    <summary type="text">Title: Depistarea tuberculozei pulmonare în grupele de risc ftizic sporit printre populaţia urbană
Authors: Iavorschi, Constantin; Emelianov, Oleg; Brumaru, Albina; Bolotnicov, Valentina; Ciubotaru, Viorica; Bilevici, Tatiana; Chipric, Nelli
Abstract: The tuberculosis incidence among the persons from the risk-groups does not exceed the&#xD;
incidence of the people from the general population. The coverage of the persons from the riskgroups&#xD;
with X-ray examination for prophylaxis from different risk-groups deviated from 56,4%&#xD;
to 82,5%.The majority of the patients (69,1%) from the risk-groups were detected by visiting the&#xD;
doctor. The number of the patients lately detected from the risk-groups (32,0%) and made no&#xD;
difference between the number the patients lately detected from the general population (##&lt;#%).&#xD;
It is necessary to revise the formation of the increased phthisical high-risk groups and to improve&#xD;
the examination of the persons from these groups.&#xD;
&#xD;
&#xD;
&#xD;
&#xD;
&#xD;
Incidenţa tuberculozei printre persoanelor din grupele de risc nu depăşeşte incidenţa&#xD;
persoanelor din populaţie obişnuită. Cuprinderea persoanelor din grupele de risc cu examenul&#xD;
radiologic cu scop profilactic din diferite grupe de risc a diviat de la 56,4% pînă la 82,5%.&#xD;
Majoritatea bolnavilor (69,1%) din grupele de risc au fost depistaţi prin adresare. Numărul&#xD;
bolnavilor tardiv depistaţi din grupele de risc (32,/%) şi nu s-au deosebit de numărul bolnavilor&#xD;
tardiv depistaţi printre populaţie obişnuită (33,3%). E necesar de reviziona formarea grupelor de&#xD;
risc ftizic sporit şi de a ameliora examinarea persoanelor în aceste grupe.
Description: MSP Institutul de Ftiziopneumologie „Chiril Draganiuc”, IMSP AMT Botanică mun.Chişinău</summary>
    <dc:date>2013-01-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Dizabilitatea îndelungată la pacienţi cu astm bronşic evoluţie uşoară</title>
    <link rel="alternate" href="http://repository.usmf.md:80/handle/20.500.12710/5997" />
    <author>
      <name>Moscovciuc, Ana</name>
    </author>
    <author>
      <name>Martîniuc, Constantin</name>
    </author>
    <author>
      <name>Simionică, Iurie</name>
    </author>
    <author>
      <name>Scaleţchi, Valentina</name>
    </author>
    <author>
      <name>Luchian, Mihai</name>
    </author>
    <author>
      <name>Colun, Tatiana</name>
    </author>
    <id>http://repository.usmf.md:80/handle/20.500.12710/5997</id>
    <updated>2019-06-26T11:47:23Z</updated>
    <published>2013-01-01T00:00:00Z</published>
    <summary type="text">Title: Dizabilitatea îndelungată la pacienţi cu astm bronşic evoluţie uşoară
Authors: Moscovciuc, Ana; Martîniuc, Constantin; Simionică, Iurie; Scaleţchi, Valentina; Luchian, Mihai; Colun, Tatiana
Abstract: In patients with persistent light forms of bronchial asthma, clinical manifestations with&#xD;
functional cardio-respiratory disturbances lead to moderate functional insufficiency, that kept&#xD;
capacity to work at the level of 95% in 6,1% of patients; 90-80% - in 62% of patients and 75-&#xD;
65% of capacity to work - in 31,8% of cases. These persons were considered able to work; 31&#xD;
patients with physical effort professional activity and noxious work conditions were transfered to &#xD;
other activity forms limited in comfort zone. In 2 patients there were installed moderate grade of&#xD;
dysability during one year for medical and professional rehabilitation.&#xD;
&#xD;
&#xD;
&#xD;
&#xD;
&#xD;
&#xD;
&#xD;
&#xD;
La pacienţi cu AB evoluţia uşoară manifestările clinice cu dereglări cardiorespiratorii&#xD;
funcţionale a adus la deficienţa funcţională uşoară, ce au menţinut capacitatea de muncă la 6,1%&#xD;
bolnavi pînă la 95%, la 62,1-90-80% şi 31,8% pînă la 75-65%. Aceste persoane au fost&#xD;
considerate apte de muncă, la 31 persoane ce prestau activitatea de muncă cu efort fizic, cu noxe&#xD;
erau transferaţi la alte activităţi în limitelei zonei de confort, la 2 persoane sa stabilit gradul mediu&#xD;
de dizabilitate pe un an pentru reabilitarea medicală şi profesională.
Description: IMSP Institutul Ftiziopneumologie „Chiril Draganiuc”, Consiliul Naţional pentru Determinarea Dizabilităţii şi Capacităţii de Muncă</summary>
    <dc:date>2013-01-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Dinamica eficacităţii tratamentului cazurilor noi de tuberculoză pulmonară în municipiul Chişinău</title>
    <link rel="alternate" href="http://repository.usmf.md:80/handle/20.500.12710/5996" />
    <author>
      <name>Ustian, Aurelia</name>
    </author>
    <author>
      <name>Vilc, Valentina</name>
    </author>
    <author>
      <name>Kulciţkaia, Stela</name>
    </author>
    <author>
      <name>Tacu, Lilia</name>
    </author>
    <author>
      <name>Cetulean, Maria</name>
    </author>
    <author>
      <name>Miciurina, Isa</name>
    </author>
    <id>http://repository.usmf.md:80/handle/20.500.12710/5996</id>
    <updated>2019-06-26T11:47:23Z</updated>
    <published>2013-01-01T00:00:00Z</published>
    <summary type="text">Title: Dinamica eficacităţii tratamentului cazurilor noi de tuberculoză pulmonară în municipiul Chişinău
Authors: Ustian, Aurelia; Vilc, Valentina; Kulciţkaia, Stela; Tacu, Lilia; Cetulean, Maria; Miciurina, Isa
Abstract: It were assessed the treatment outcomes of 1519 patients with pulmonary tuberculosis.&#xD;
The data evidences show the presence of 53,0% of patients that eliminates Koch bacili, 49,9%&#xD;
patients with resistant forms of tuberculosis and 71,6% with multi-drugs resistant&#xD;
forms.succesesful treatment was noted in 67,5 (cured – 18,0%, treatment completed – 49,5%). &#xD;
Unsuccessful of treatment was recorded in 22,1% (failure, abandonment, death) mostly in&#xD;
patients with M+C+. Extend treatment DOTS+ 8,5%, 1,9% patients were transferred&#xD;
&#xD;
&#xD;
&#xD;
&#xD;
&#xD;
&#xD;
&#xD;
&#xD;
Au fost evaluate rezultatele tratamentului a 1519 bolnavi de tuberculoză pulmonară.&#xD;
Baciliferi erau 53,0%, forme rezistente – 49,9% din care MDR au constitut 71,6%. Succesul&#xD;
tratamentului s-a consatat la 67,5% (vindecat – 18,0%, tratament încheiat – 49,5%). Insuccesul&#xD;
tratamentului s-a înregistrat la 22,1% (eşec, abandon, deces) preponderent la bolnavii cu&#xD;
M+C+, prelungesc tratamentul DOTS+ 8,5%, iar 1,9% pacienţi au fost transferaţi.
Description: Catedra pneumoftiziologie, USMF „Nicolae Testemiţanu”, IMSP Spitalul Clinic Municipal de Pneumoftiziologie, Chişinău</summary>
    <dc:date>2013-01-01T00:00:00Z</dc:date>
  </entry>
</feed>

